Paul Hartmann AG - Asset Resilience Ratio
Paul Hartmann AG (PHH2) has an Asset Resilience Ratio of 0.17% as of December 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PHH2 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2019)
This chart shows how Paul Hartmann AG's Asset Resilience Ratio has changed over time. See Paul Hartmann AG net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Paul Hartmann AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Paul Hartmann AG.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €2.67 Million | 0.17% |
| Total Liquid Assets | €2.67 Million | 0.17% |
Asset Resilience Insights
- Limited Liquidity: Paul Hartmann AG maintains only 0.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Paul Hartmann AG Industry Peers by Asset Resilience Ratio
Compare Paul Hartmann AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Paul Hartmann AG (2016–2019)
The table below shows the annual Asset Resilience Ratio data for Paul Hartmann AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-12-31 | 0.17% | €2.67 Million ≈ $3.12 Million |
€1.61 Billion ≈ $1.88 Billion |
+0.16pp |
| 2018-12-31 | 0.00% | €14.00K ≈ $16.37K |
€1.50 Billion ≈ $1.75 Billion |
-0.90pp |
| 2017-12-31 | 0.90% | €12.94 Million ≈ $15.13 Million |
€1.43 Billion ≈ $1.67 Billion |
+0.89pp |
| 2016-12-31 | 0.02% | €201.00K ≈ $234.99K |
€1.33 Billion ≈ $1.55 Billion |
-- |
About Paul Hartmann AG
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more